SCHEMBL19911348

SCHEMBL19911348

CCCCCCCCN(CCCCCCCC)CCn1cnc2cc(OC)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.50
HSD17B10 Q99714 4/20 0.50
MAPT P10636 6/20 0.48
GAA P10253 2/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
ALDH1A1 P00352 2/20 0.47
ALOX15 P16050 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
FGFR1 P11362 4/20 0.42
LMNA P02545 2/20 0.42
NR1I2 O75469 1/20 0.42
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
HPGD P15428 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
PLA2G4A P47712 1/20 0.40
ATP4A P20648 1/20 0.40
ATP4B P51164 1/20 0.40
MEN1 O00255 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19911360 0.91 MTNR1A (0.52) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL19911350 0.89 MAPT (0.44) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL7874916 0.86 MAPT (0.55) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL19848227 0.85 MAPT (0.58) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL19911329 0.84 LMNA (0.48) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL19911428 0.83 ICMT (0.46) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL19911411 0.83 MAPT (0.62) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL19848077 0.82 MAPT (0.65) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL23927890 0.81 HTR2A (0.55) KDM4EHSD17B10MAPTGAANPC1
SCHEMBL19915706 0.80 MTNR1A (0.51) KDM4EHSD17B10MAPTGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10756394-B2 Nonaqueous electrolyte and nonaqueous secondary battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-08-25 US disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10756394-B2 Nonaqueous electrolyte and nonaqueous secondary battery BPTF, BRD4, KCNN2 KDM4E 2256/4885HSD17B10 2395/4885MAPT 1283/4885
US-20180062213-A1 Nonaqueous Electrolyte and Nonaqueous Secondary Battery BPTF, BRD4, KCNN2 KDM4E 2256/4885HSD17B10 2395/4885MAPT 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.